CRITEO S A's ticker is CRTO and the CUSIP is 226718104. A total of 134 filers reported holding CRITEO S A in Q3 2023. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,446,000 | +10.3% | 255,000 | +27.5% | 2.40% | +18.9% |
| Q2 2023 | $6,748,000 | +36.7% | 200,000 | +27.6% | 2.02% | +7.8% |
| Q1 2023 | $4,936,834 | -21.5% | 156,700 | -35.1% | 1.88% | -51.6% |
| Q4 2022 | $6,291,405 | +61.6% | 241,420 | +67.7% | 3.88% | +112.0% |
| Q3 2022 | $3,892,000 | +165.8% | 144,000 | +140.0% | 1.83% | +346.9% |
| Q2 2022 | $1,464,000 | -57.3% | 60,000 | -52.4% | 0.41% | -69.8% |
| Q1 2022 | $3,432,000 | -59.5% | 126,000 | -42.2% | 1.36% | -40.0% |
| Q4 2021 | $8,467,000 | +60.6% | 217,822 | +51.4% | 2.26% | +53.0% |
| Q3 2021 | $5,273,000 | -52.4% | 143,883 | -41.2% | 1.48% | -46.5% |
| Q2 2021 | $11,072,000 | +51.8% | 244,800 | +16.6% | 2.76% | +36.5% |
| Q1 2021 | $7,294,000 | +188.3% | 210,000 | +70.2% | 2.02% | +169.2% |
| Q4 2020 | $2,530,000 | +635.5% | 123,373 | +516.9% | 0.75% | +541.9% |
| Q2 2019 | $344,000 | -14.2% | 20,000 | 0.0% | 0.12% | -42.1% |
| Q1 2019 | $401,000 | +7920.0% | 20,000 | +9900.0% | 0.20% | +6633.3% |
| Q3 2018 | $5,000 | -99.7% | 200 | -99.7% | 0.00% | -99.7% |
| Q1 2018 | $1,504,000 | +188.7% | 58,200 | +191.0% | 1.03% | +344.2% |
| Q4 2017 | $521,000 | – | 20,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RPD Fund Management LLC | 909,494 | $24,775,000 | 13.44% |
| Metavasi Capital LP | 736,916 | $20,074,000 | 10.84% |
| DENDUR CAPITAL LP | 1,367,000 | $37,237,000 | 6.39% |
| Orchard Capital Management, LLC | 461,793 | $12,579,000 | 3.58% |
| Cannell Capital | 635,990 | $17,324,000 | 2.62% |
| No Street GP LP | 640,000 | $17,434,000 | 2.36% |
| Bpifrance SA | 2,718,752 | $74,059,000 | 2.07% |
| BlueCrest Capital Management Ltd | 2,260,000 | $61,562,000 | 2.01% |
| Lapides Asset Management, LLC | 146,200 | $3,982,000 | 1.75% |
| Metavasi Capital LP | 76,300 | $2,078,000 | 1.12% |